Original research: Deactivation of ICDs at the end of life: A systematic review of clinical practices and provider and patient attitudes

American Journal of Nursing

Volumn 111, Issue 10, 2011, Pages 26-35

  Russo, James E ^a  

^a Department of Veterans   (United States)

Author keywords

cardiac arrhythmia; cardiac implantable electronic device; deactivation; defibrillation; end of life care; heart failure; hospice care; implantable cardioverter defibrillator; palliative care; ventricular tachyarrhythmia

Indexed keywords

ATTITUDE TO HEALTH; DEFIBRILLATOR; ETHICS; HEALTH PERSONNEL ATTITUDE; HUMAN; PRACTICE GUIDELINE; REVIEW; TERMINAL CARE;

ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; DEFIBRILLATORS, IMPLANTABLE; ETHICS; GUIDELINES AS TOPIC; HUMANS; TERMINAL CARE;

EID: 80053566407     PISSN: 0002936X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.NAJ.0000406411.49438.91     Document Type: Review

References (56)

1. Grassman D. EOL considerations in defibrillator deactivation. Am J Hosp Palliat Care 2005;22(3):179-80.
2. Mirowski M, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980;303(6):322-4. (Pubitemid 10040022)
3. Fishman GI, et al. Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. Circulation 2010; 122(22):2335-48.
4. Moss AJ, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335(26):1933-40. (Pubitemid 26428217)
5. Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337( 22): 1576-83.
6. Moss AJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346(12):877-83. (Pubitemid 34984635)
7. Buxton AE, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341(25):1882-90.
8. Bardy GH, et al. Amiodarone or an implantable cardioverterdefibrillator for congestive heart failure. N Engl J Med 2005; 352(3):225-37. (Pubitemid 40110811)
9. Goldberger Z, Lampert R. Implantable cardioverterdefibrillators: expanding indications and technologies. JAMA 2006;295(7):809-18. (Pubitemid 43244308)
10. Hammill SC, et al. Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure. Heart Rhythm 2010;7(9): 1340-5.
11. Goldstein NE, et al. "That's like an act of suicide" patients' attitudes toward deactivation of implantable defibrillators. J Gen Intern Med 2008;23 Suppl 1:7-12. (Pubitemid 350295388)
12. Goldstein NE, et al. "It's like crossing a bridge" complexities preventing physicians from discussing deactivation of implantable defibrillators at the end of life. J Gen Intern Med 2008;23 Suppl 1:2-6. (Pubitemid 350295386)
13. Hauptman PJ, et al. Physician attitudes toward end-stage heart failure: a national survey. Am J Med 2008;121(2): 127-35. (Pubitemid 351199454)
14. Marinskis G, van Erven L. Deactivation of implanted cardioverter- defibrillators at the end of life: results of the EHRA survey. Europace 2010;12(8):1176-7.
15. Kenny T. The nuts and bolts of ICD therapy. Malden, MA: Blackwell Futura; 2006.
16. Wathen MS, et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation 2004;110(17):2591-6. (Pubitemid 39453007)
17. Stewart GC, et al. Patient expectations from implantable defibrillators to prevent death in heart failure. J Card Fail 2010;16(2):106-13.
18. Paola FA, Walker RM. Deactivating the implantable cardioverter- defibrillator: a biofixture analysis. South Med J 2000;93(1):20-3. (Pubitemid 30058982)
19. Kutalek SP, et al. Approach to generator change. In: Ellenbogen KA, et al., editors. Clinical cardiac pacing, defibrillation, and resynchronization therapy. 3rd ed. Philadelphia: Saunders, Elsevier; 2007. p. 827-53.
20. Kirk TW. Deactivation of automatic implantable cardioverterdefibrillators in hospice and home care patients at the end of life. Home Healthc Nurse 2008;26(7):431-7.
21. Nambisan V, Chao D. Dying and defibrillation: a shocking experience. Palliat Med 2004;18(5):482-3. (Pubitemid 39162662)
22. Wiegand DL, Kalowes PG. Withdrawal of cardiac medications and devices. AACN Adv Crit Care 2007;18(4):415-25.
23. Kelly M. Death and defibrillators: implanted devices keep shocking as heartbeat changes near life's end. Charleston Gazette 2006 Jun 26.
24. Meier B. Lifesaving devices can cause havoc at life's end. New York Times 2010 May 13. http://www.nytimes.com/2010/05/14/health/14device.html.
25. Berger JT. The ethics of deactivating implanted cardioverter defibrillators. Ann Intern Med 2005;142(8):631-4. (Pubitemid 40529960)
26. Bogan C, et al. Deactivation of an implantable cardioverter defibrillator in a dying patient. Ir Med J 2006;99(5):155-6.
27. Looi YC. And it can go on and on and on. J Pain Symptom Manage 2006;31(1):1-2.
28. Plunkitt K, et al. Ethical issues in the management of geriatric cardiac patients: a patient is asking his cardiologist to deactivate an implantable cardioverter defibrillator device in order to allow him to die. Am J Geriatr Cardiol 1998;7(2):43-4.
29. Withell B. Patient consent and implantable cardioverter defibrillators: some palliative care implications. Int J Palliat Nurs 2006;12(10):470-5.
30. Braun TC, et al. Cardiac pacemakers and implantable defibrillators in terminal care. J Pain Symptom Manage 1999; 18(2):126-31. (Pubitemid 29409441)
31. Kirkpatrick JN, et al. Ethical dilemmas in device treatment for advanced heart failure. Curr Opin Support Palliat Care 2007;1(4):267-73.
32. Sears SF, et al. Quality of death: implantable cardioverter defibrillators and proactive care. Pacing Clin Electrophysiol 2006;29(6):637-42. (Pubitemid 43886617)
33. Yager JEE, Rogers JG. End-of-life care in patients with heart failure. Prog Palliat Care 2005;13(3):139-45. (Pubitemid 41288683)
34. Ballentine JM. Pacemaker and defibrillator deactivation in competent hospice patients: an ethical consideration. Am J Hosp Palliat Care 2005;22(1):14-9. (Pubitemid 40208759)
35. Basta LL. End-of-life and other ethical issues related to pacemaker and defibrillator use in the elderly. Am J Geriatr Cardiol 2006;15(2):114-7.
36. Salber KE. Ethical issues in defibrillator patients' quality of life. IEEE Eng Med Biol Mag 2007;26(3):84-7. (Pubitemid 46848767)
37. Mueller PS, et al. Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support at the end of life. Mayo Clin Proc 2003;78(8):959-63. (Pubitemid 36936127)
38. Cantor NL. On hastening death without violating legal and moral prohibitions. Spec Law Dig Health Care Law 2007(338): 9-31.
39. Kay RS. Causing death for compassionate reasons in American law. Am J Comp Law 2006;54(Fall):693-716. (Pubitemid 44946200)
40. Snyder L, Leffler C. Ethics manual: fifth edition. Ann Intern Med 2005;142(7):560-82.
41. Truog RD. End-of-life decision-making in the United States. Eur J Anaesthesiol Suppl 2008;42:43-50. (Pubitemid 351643067)
42. Agard A, et al. Views of patients with heart failure about their role in the decision to start implantable cardioverter defibrillator treatment: prescription rather than participation. J Med Ethics 2007;33(9):514-8.
43. Wu EB. The ethics of implantable devices. J Med Ethics 2007;33(9):532-3.
44. Lampert R, et al. HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm 2010;7(7): 1008-26.
45. Epstein AE, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary. Heart Rhythm 2008;5(6):934-55.
46. Goldstein N, et al. Barriers to conversations about deactivation of implantable defibrillators in seriously ill patients: results of a nationwide survey comparing cardiology specialists to primary care physicians. J Am Coll Cardiol 2009; 54(4):371-3.
47. Goldstein N, et al. Brief communication: management of implantable cardioverter-defibrillators in hospice: a nationwide survey. Ann Intern Med 2010;152(5):296-9.
48. Goldstein NE, et al. Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med 2004;141(11): 835-8. (Pubitemid 39601176)
49. Kelley AS, et al. Management of patients with ICDs at the end of life (EOL): a qualitative study. Am J Hosp Palliat Care 2008;25(6):440-6.
50. Kelley AS, et al. Implantable cardioverter-defibrillator deactivation at the end of life: a physician survey. Am Heart J 2009;157(4):702-8, e1.
51. Kobza R, Erne P. End-of-life decisions in ICD patients with malignant tumors. Pacing Clin Electrophysiol 2007;30(7): 845-9. (Pubitemid 46955404)
52. Lewis WR, et al. Withdrawing implantable defibrillator shock therapy in terminally ill patients. Am J Med 2006;119(10): 892-6. (Pubitemid 44415609)
53. Mueller PS, et al. Deactivating implanted cardiac devices in terminally ill patients: practices and attitudes. Pacing Clin Electrophysiol 2008;31(5):560-8. (Pubitemid 351595284)
54. Sherazi S, et al. Physicians' preferences and attitudes about end-of-life care in patients with an implantable cardioverter-defibrillator. Mayo Clin Proc 2008;83(10): 1139-41.
55. Carroll SL. A potential barrier to discussing deactivation of implantable cardioverter defibrillators was patients' lack of knowledge. Evid Based Nurs 2008;11(3):95.
56. Lipman HI. Deactivation of advanced lifesaving technologies. Am J Geriatr Cardiol 2007;16(2):109-11.